Page last updated: 2024-12-08

mycarose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mycarose: RN given refers to (L-ribo)-isomer; structure given in first source; epi-axenose to lyxo configeration [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID169005
CHEBI ID31010
SCHEMBL ID489381
MeSH IDM0133083

Synonyms (25)

Synonym
CHEBI:31010
3-epi-axenose
6032-92-4
2,6-dideoxy-3-c-methyl-l-ribo-hexose
mycarose
(3r,4s,5s)-3,4,5-trihydroxy-3-methylhexanal
2,6-dideoxy-3-c-methyl-lyxo-hexose
unii-21mjv8677v
l-ribo-hexose, 2,6-dideoxy-3-c-methyl-
21mjv8677v ,
2,6-dideoxy-3-c-methyl-ribo-hexose
mycarose [mi]
2,6-dideoxy-3-c-methyl-l-ribohexose
SCHEMBL489381
unii-i71i3dg1w1
I71I3DG1W1 ,
92345-04-5
mycarose dl- form [mi]
mycarose, (+/-)-
mycarose, dl-
ribo-hexose, 2,6-dideoxy-3-c-methyl-
Q27114061
DTXSID30975732
2,6-dideoxy-3-c-methylhexose
AKOS040753173
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dideoxyhexose derivativeA deoxyhexose derivative that is formally obtained from a dideoxyhexose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's3 (18.75)18.2507
2000's10 (62.50)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.10 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]